These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 30742062)

  • 1. Association between TDP-43 and mitochondria in inclusion body myositis.
    Huntley ML; Gao J; Termsarasab P; Wang L; Zeng S; Thammongkolchai T; Liu Y; Cohen ML; Wang X
    Lab Invest; 2019 Jul; 99(7):1041-1048. PubMed ID: 30742062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies.
    Hiniker A; Daniels BH; Lee HS; Margeta M
    Acta Neuropathol Commun; 2013 Jul; 1():29. PubMed ID: 24252466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis.
    Cykowski MD; Powell SZ; Appel JW; Arumanayagam AS; Rivera AL; Appel SH
    Acta Neuropathol Commun; 2018 Apr; 6(1):28. PubMed ID: 29653597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis.
    Salajegheh M; Pinkus JL; Taylor JP; Amato AA; Nazareno R; Baloh RH; Greenberg SA
    Muscle Nerve; 2009 Jul; 40(1):19-31. PubMed ID: 19533646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions.
    Mori F; Tada M; Kon T; Miki Y; Tanji K; Kurotaki H; Tomiyama M; Ishihara T; Onodera O; Kakita A; Wakabayashi K
    Acta Neuropathol Commun; 2019 Oct; 7(1):165. PubMed ID: 31661037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of NBR1, a novel autophagy-associated protein, in muscle fibers of sporadic inclusion-body myositis.
    D'Agostino C; Nogalska A; Cacciottolo M; Engel WK; Askanas V
    Acta Neuropathol; 2011 Nov; 122(5):627-36. PubMed ID: 21935636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis.
    Britson KA; Ling JP; Braunstein KE; Montagne JM; Kastenschmidt JM; Wilson A; Ikenaga C; Tsao W; Pinal-Fernandez I; Russell KA; Reed N; Mozaffar T; Wagner KR; Ostrow LW; Corse AM; Mammen AL; Villalta SA; Larman HB; Wong PC; Lloyd TE
    Sci Transl Med; 2022 Jan; 14(628):eabi9196. PubMed ID: 35044790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal TDP-43 and FUS proteins in muscles of sporadic IBM: similarities in a TARDBP-linked ALS patient.
    Hernandez Lain A; Millecamps S; Dubourg O; Salachas F; Bruneteau G; Lacomblez L; LeGuern E; Seilhean D; Duyckaerts C; Meininger V; Mallet J; Pradat PF
    J Neurol Neurosurg Psychiatry; 2011 Dec; 82(12):1414-6. PubMed ID: 20562395
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis.
    Dubourg O; Wanschitz J; Maisonobe T; Béhin A; Allenbach Y; Herson S; Benveniste O
    Acta Myol; 2011 Oct; 30(2):103-8. PubMed ID: 22106712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAR DNA-Binding protein 43 accumulation in protein aggregate myopathies.
    Olivé M; Janué A; Moreno D; Gámez J; Torrejón-Escribano B; Ferrer I
    J Neuropathol Exp Neurol; 2009 Mar; 68(3):262-73. PubMed ID: 19225410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-Cell-Mediated Inflammatory Myopathies in HIV-Positive Individuals: A Histologic Study of 19 Cases.
    Hiniker A; Daniels BH; Margeta M
    J Neuropathol Exp Neurol; 2016 Mar; 75(3):239-45. PubMed ID: 26843609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenic considerations in sporadic inclusion-body myositis, a degenerative muscle disease associated with aging and abnormalities of myoproteostasis.
    Askanas V; Engel WK; Nogalska A
    J Neuropathol Exp Neurol; 2012 Aug; 71(8):680-93. PubMed ID: 22805774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No mutations in hnRNPA1 and hnRNPA2B1 in Dutch patients with amyotrophic lateral sclerosis, frontotemporal dementia, and inclusion body myopathy.
    Seelen M; Visser AE; Overste DJ; Kim HJ; Palud A; Wong TH; van Swieten JC; Scheltens P; Voermans NC; Baas F; de Jong JM; van der Kooi AJ; de Visser M; Veldink JH; Taylor JP; Van Es MA; van den Berg LH
    Neurobiol Aging; 2014 Aug; 35(8):1956.e9-1956.e11. PubMed ID: 24612671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis.
    Nogalska A; Terracciano C; D'Agostino C; King Engel W; Askanas V
    Acta Neuropathol; 2009 Sep; 118(3):407-13. PubMed ID: 19557423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing.
    Hedberg-Oldfors C; Lindgren U; Basu S; Visuttijai K; Lindberg C; Falkenberg M; Larsson Lekholm E; Oldfors A
    Brain Pathol; 2021 May; 31(3):e12931. PubMed ID: 33354847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy.
    Lodi R; Taylor DJ; Tabrizi SJ; Hilton-Jones D; Squier MV; Seller A; Styles P; Schapira AH
    Brain; 1998 Nov; 121 ( Pt 11)():2119-26. PubMed ID: 9827771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration.
    Gao J; Wang L; Yan T; Perry G; Wang X
    Mol Cell Neurosci; 2019 Oct; 100():103396. PubMed ID: 31445085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS.
    Al-Sarraj S; King A; Troakes C; Smith B; Maekawa S; Bodi I; Rogelj B; Al-Chalabi A; Hortobágyi T; Shaw CE
    Acta Neuropathol; 2011 Dec; 122(6):691-702. PubMed ID: 22101323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the Unfolded Protein Response in Sporadic Inclusion-Body Myositis but Not in Hereditary GNE Inclusion-Body Myopathy.
    Nogalska A; D'Agostino C; Engel WK; Cacciottolo M; Asada S; Mori K; Askanas V
    J Neuropathol Exp Neurol; 2015 Jun; 74(6):538-46. PubMed ID: 25978849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory myopathies with mitochondrial pathology and protein aggregates.
    Temiz P; Weihl CC; Pestronk A
    J Neurol Sci; 2009 Mar; 278(1-2):25-9. PubMed ID: 19101700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.